Not a healthcare professional? Go to the patient or caregiver website.

NYVEPRIA Overdosage (pegfilgrastim-apgf)

10 OVERDOSAGE

Overdosage of pegfilgrastim products may result in leukocytosis and bone pain. Events of edema, dyspnea, and pleural effusion have been reported in a single patient who administered pegfilgrastim on 8 consecutive days in error. In the event of overdose, the patient should be monitored for adverse reactions [see Adverse Reactions (6)].

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No